Admission Date:  [**2145-8-24**]       Discharge Date:  [**2145-9-29**]

Date of Birth:   [**2086-4-7**]       Sex:  M

Service:

HOSPITAL COURSE:  The patient continued to slowly improve
while in the Intensive Care Unit.  He completed a full
recommended course of intravenous Zosyn.  On [**2145-9-15**], ................... lavage obtained from a bronchoscopy
showed a Staphylococcus aureus that was MRSA but sensitive to
Vancomycin.  The patient still continued to have mild
leukocytosis.  Given the sensitivities, intravenous
Vancomycin was started on [**2145-9-20**].

On [**2145-9-20**], a speech and swallow test was
performed.  Speech and swallow test showed increased risk of
aspiration.  The patient was transferred to the regular floor
on [**2145-9-24**].  The patient was continued on tube feeds.
The patient still continued to have a moderate amount of
secretions that were mostly yellowish in color and thick in
consistency.  The patient was continued on intravenous
Vancomycin.

The patient was ambulating.  His chest x-ray showed some
interval improvement.  The patient remained in regular
rhythm.  He was tolerating his tube feeds well.  A
video-assisted speech and swallow was repeated on [**2145-9-27**], which still showed the risk of aspiration.  The patient
was discharged to the rehabilitation facility on [**2145-9-29**], in stable condition.

CONDITION ON DISCHARGE:  Stable.

DISCHARGE DISPOSITION:  To the rehabilitation facility.

DISCHARGE DIAGNOSIS:
1.  Lung cancer status post right lower lobe resection.
2.  Methicillin resistant staphylococcus aureus aspiration
pneumonia.
3.  ARDS.
4.  Hypertension.
5.  Hypercholesterolemia.

DISCHARGE MEDICATIONS:  Lopressor 150 mg p.o. t.i.d.,
Lisinopril 20 mg p.o. q.d., Lipitor 40 mg p.o. q.d.,
Neurontin 300 mg p.o. q.d., Vancomycin 1 g IV q.12 hours x 4
days to start on [**2145-9-29**], Colace 100 mg p.o. b.i.d.
p.r.n. constipation, Albuterol 4 puffs inhaler q.4 hours,
Ipratropium Bromide 4 puffs inhaler q.4 hours, Tylenol 325 mg
p.o. q.4-6 hours p.r.n. pain, Nystatin oral suspension 5 ml
p.o. q.i.d. p.r.n.

DISCHARGE INSTRUCTIONS:  The patient is to follow-up with Dr.
[**Last Name (STitle) 175**], his surgeon, in approximately two weeks.  The patient
is to follow-up with his primary care physician in
approximately 1-2 weeks.  The patient is to follow-up with
Infectious Disease physician within the next month.




                   DR.[**Last Name (STitle) **],[**First Name3 (LF) 177**] 02-177



Dictated By:[**Last Name (NamePattern1) 1741**]
MEDQUIST36

D:  [**2145-9-29**]  10:09
T:  [**2145-9-29**]  12:20
JOB#:  [**Job Number 44472**]
